268235325 | PUO | 00601670 | | 972549 | 5/3/2002 12:00:00 AM | CAD | | DIS | Admission Date: 10/17/2002 Report Status: 

Discharge Date: 6/17/2002 ****** DISCHARGE ORDERS ****** WRAGG , DONETTE D 774-32-55-5 Roll Service: CAR DISCHARGE PATIENT ON: 7/14/02 AT 04:00 PM CONTINGENT UPON Not Applicable WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: BERNAS , RUFUS CARLIE , M.D. CODE STATUS: Full code DISPOSITION: Home DISCHARGE MEDICATIONS: ALBUTEROL INHALER 2 PUFF INH QID PRN sob ECASA ( ASPIRIN ENTERIC COATED ) 325 MG PO QD FOLATE ( FOLIC ACID ) 1 MG PO QD LASIX ( FUROSEMIDE ) 40 MG PO BID Override Notice: Override added on 10/20/02 by SENGBUSCH , SHALANDA Y. , M.D. on order for DILTIAZEM PO ( ref # 23434636 ) POTENTIALLY SERIOUS INTERACTION: FUROSEMIDE &amp; DILTIAZEM HCL Reason for override: will monitor Previous override information: Override added on 10/20/02 by PORTNOY , SHANEL YVONE , M.D. on order for DILTIAZEM EXTENDED RELEASE PO ( ref # 00093447 ) POTENTIALLY SERIOUS INTERACTION: FUROSEMIDE &amp; DILTIAZEM HCL Reason for override: will monitor Previous override information: Override added on 10/20/02 by PORTNOY , SHANEL YVONE , M.D. on order for DILTIAZEM PO ( ref # 98048355 ) POTENTIALLY SERIOUS INTERACTION: FUROSEMIDE &amp; DILTIAZEM HCL Reason for override: md aware HYDRALAZINE HCL 25 MG PO BID Food/Drug Interaction Instruction Take consistently with meals or on empty stomach. 
ZOCOR ( SIMVASTATIN ) 40 MG PO QHS Food/Drug Interaction Instruction Avoid grapefruit unless MD instructs otherwise. 
AMARYL ( GLIMEPIRIDE ) 2 MG PO QD Number of Doses Required ( approximate ): 4 CLOPIDOGREL 75 MG PO QD Starting START THE NEXT DAY AVAPRO ( IRBESARTAN ) 150 MG PO QD Number of Doses Required ( approximate ): 4 DILTIAZEM SR 120 MG PO QOD DIET: House / Low chol/low sat. 
fat Activity - As tolerated RETURN TO WORK: Immediately FOLLOW UP APPOINTMENT( S ): MMC cardiology appointment will be arranged for 3 weeks , No Known Allergies ADMIT DIAGNOSIS: cad PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) CAD OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay asthma CVA CAD Hemorrhagic stroke s/p CABG ( S/P cardiac bypass graft surgery ) dm ( diabetes mellitus ) anxiety d/o ( anxiety ) osa ( sleep apnea ) hypercholesterolemia ( elevated cholesterol ) htn ( hypertension ) OPERATIONS AND PROCEDURES: OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) Cardiac Catheterization with L PDA stenting BRIEF RESUME OF HOSPITAL COURSE: 65 yo male with HTN , CAD , DM , and hypercholesterolemia who presents with 3 episodes of exertional CP over the last 3 days. 
On 9/21/02 the patient had his forst episode of SSCP while pushing a grocery cart. 
It was associated with SOB above the patient's baseline. 
There was no associated n/v or diaphoresis. 
The pain resolved over 45 minutes with rest. 
The pt. again experienced exertional CP while walking on Monday 9/4/02 .  
The thrid episode of CP was onthe morning of 4/2/02 while the patient descended stairs. 
The pain was 7/10 and continued until the patient saw his PCP shortly there after and was given two SL NTG. 
EKG at PCP office was unchanged from baseline. 
The patient reports that he has not had CP similar to this since his CABG which was in 1995. 
He denies PND , orthopnea , LE edema. 
EXAM Notable for JVP of 8 cm , clear chest , regular cardaic exam and only trace edema in extremities. 
No femoral bruits with 2+ dp and pt pulses. 
HOSPITAL COURSE Pt. went for left heart cath on 9/30/02 which revea led a left dominant system with 80% distal LCx/LPDA occlusion which was stanted; the cath als o revealed 100% occlusion of SVG-LfPDA and 100 % SVG-marg 2and 70% prox. 
RCA. 
PLAN 1. CV - ischemia - Continue home ischemia regimen with ASA , avapro and zocor. 
B blocker help secondary to asthma attack in past with lopressor. 
Heparin held secondary to history of CVA on anticoagulation. 
Rate/rhythm - telemetry. 
Pump - No signs/sx. 
failure. 
2. Renal - Baseline Cr 1.3; will recieve mucomyst for renal protection with cath. 
3. Endo - Will place the patient on RISS and continue on amaryl. 
4. Pulmonary - Will continue hime regimen of CPAP for OSA. 
ADDITIONAL COMMENTS: DISCHARGE CONDITION: Stable TO DO/PLAN: No dictated summary ENTERED BY: PORTNOY , SHANEL YVONE , M.D. ( SE88 ) 7/14/02 @ 03:55 PM ****** END OF DISCHARGE ORDERS ******